NCT07426458PHASE4Recruiting
Ventilation and Perfusion in Asthmatics
University of Miami
Start Date
4/27/2026
Completion Date
4/1/2028
Summary
Assess regional changes to perfusion and ventilation from inhaled corticosteroid (ICS) and Fast-acting beta-antagonist (FABA) among adult asthmatics using radiographically derived estimates of regional ventilation (V-distribution), ventilation defect percentage (VDP), and ventilation heterogeneity (VH).
Eligibility Criteria
Age Range: 18 years to 75 years
Inclusion Criteria:
* Physician diagnosis of asthma
* Baseline Forced Expiratory Volume in 1 Second (FEV1) \< 80% of predicted, with reversibility (10%) on post-bronchodilator spirometry
* Adults, 18-75 years of age
* Long-term inhaled controller medication consisting of or including an Inhaled corticosteroids (ICS) at a steady dose for at least 3 months before enrollment
Exclusion Criteria:
* Current cigarette smoking or a past history of \>10 pack-year smoking
* Current nicotine vaping
* Pregnant and breast-feeding women
* Respiratory infection within 4 weeks of proposed study date
* Forced Expiratory Volume in 1 Second (FEV1) \< 50%
* Inhaled corticosteroids (ICS)/fast-acting beta agonist (FABA) intolerance
* Use of beta-blockers
* Use of systemic glucocorticosteroids or oral methyl-xanthines within 30 days of planned study visit.
Interventions
DRUG
Albuterol Sulfate
DRUG
Albuterol-Budesonide
Conditions
Asthma
Locations
University of Miami - Converge Miami
Miami, Florida 33136
United States